Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2025-12-12
• Last 15 days FTD volume: NZ$0.08 M
• Last 3 months FTD volume: NZ$35.08 M
• Last 12 months FTD volume: NZ$0.24 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	NZ$23.42 M	NZ$0.20 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	NZ$47.76 M	NZ$0.10 B	🇺🇸 USA
AbbVie ABBV	NZ$22.65 M	NZ$90.57 M	🇺🇸 USA
Illumina ILMN	NZ$6.06 M	NZ$26.57 M	🇺🇸 USA
Biogen BIIB	NZ$3.38 M	NZ$79.73 M	🇺🇸 USA
Pfizer PFE	NZ$27.68 M	NZ$0.10 B	🇺🇸 USA
Johnson & Johnson JNJ	NZ$55.75 M	NZ$0.10 B	🇺🇸 USA
Eli Lilly LLY	NZ$0.28 B	NZ$0.42 B	🇺🇸 USA
Merck MRK	NZ$16.99 M	NZ$0.16 B	🇺🇸 USA